The results of the second randomised controlled trial (RCT) examining the efficacy of the Lenire tinnitus therapy system have now been published in the respected journal “Nature – Scientific Reports”.
TENT-A2 clinical trial
Demonstrating greater relief from tinnitus
TENT-A2 shows that optimizing treatment plans can result in greater reduction in tinnitus symptoms, which can be sustained for 12 months after treatment.